1. Home
  2. CVAC vs CRF Comparison

CVAC vs CRF Comparison

Compare CVAC & CRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • CRF
  • Stock Information
  • Founded
  • CVAC 2000
  • CRF 1973
  • Country
  • CVAC Germany
  • CRF United States
  • Employees
  • CVAC N/A
  • CRF N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • CRF Finance/Investors Services
  • Sector
  • CVAC Health Care
  • CRF Finance
  • Exchange
  • CVAC Nasdaq
  • CRF Nasdaq
  • Market Cap
  • CVAC 818.8M
  • CRF 926.5M
  • IPO Year
  • CVAC 2020
  • CRF N/A
  • Fundamental
  • Price
  • CVAC $3.30
  • CRF $8.85
  • Analyst Decision
  • CVAC Hold
  • CRF
  • Analyst Count
  • CVAC 3
  • CRF 0
  • Target Price
  • CVAC $10.00
  • CRF N/A
  • AVG Volume (30 Days)
  • CVAC 617.5K
  • CRF 620.5K
  • Earning Date
  • CVAC 11-12-2024
  • CRF 01-01-0001
  • Dividend Yield
  • CVAC N/A
  • CRF 17.97%
  • EPS Growth
  • CVAC N/A
  • CRF N/A
  • EPS
  • CVAC N/A
  • CRF N/A
  • Revenue
  • CVAC $70,565,734.00
  • CRF N/A
  • Revenue This Year
  • CVAC $742.57
  • CRF N/A
  • Revenue Next Year
  • CVAC N/A
  • CRF N/A
  • P/E Ratio
  • CVAC N/A
  • CRF N/A
  • Revenue Growth
  • CVAC 75.11
  • CRF N/A
  • 52 Week Low
  • CVAC $2.22
  • CRF $6.05
  • 52 Week High
  • CVAC $5.28
  • CRF $8.56
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 39.12
  • CRF 48.17
  • Support Level
  • CVAC $3.53
  • CRF $8.81
  • Resistance Level
  • CVAC $3.72
  • CRF $9.12
  • Average True Range (ATR)
  • CVAC 0.18
  • CRF 0.11
  • MACD
  • CVAC -0.06
  • CRF -0.01
  • Stochastic Oscillator
  • CVAC 10.96
  • CRF 47.12

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About CRF Cornerstone Total Return Fund Inc. (The)

Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology; Health Care; Financials; Communication Services; Consumer Discretionary; Industrials; Exchange-Traded Funds; Utilities; Energy; Real Estate and others.

Share on Social Networks: